Scientific Literature Search

Source record

Gene therapy for dopamine replacement.

Björklund T, Cederfjäll EA, Kirik D.

Prog Brain Res · 2010-01-01

DOI: 10.1016/s0079-6123(10)84012-9PMID: 20887878

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Neurotrophic factor therapy for Parkinson's disease.

Rangasamy SB, Soderstrom K, Bakay RA, Kordower JH.

Prog Brain Res · 2010-01-01

DOI: 10.1016/s0079-6123(10)84013-0PMID: 20887879

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[New concepts of pathogenesis, diagnosis, and treatment of neurodegenerative diseases].

Ugriumov MV.

Vestn Ross Akad Med Nauk · 2010-01-01

PMID: 20919532

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (Duodopa®) in Sweden.

Willis M, Persson U, Zoellner Y, Gradl B.

Appl Health Econ Health Policy · 2010-01-01

DOI: 10.2165/11531160-000000000-00000PMID: 21043539

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Update on current care guidelines. The diagnosis and medical treatment of memory disorders].

Suhonen J, Pirttilä T, Erkinjuntti T, Koponen H, Makkonen M, Puurunen M, Raivio M, Rinne J, Rosenvall A, Strandberg T, Vanninen R, Vataja R, Suomalaisen Lääkäriseuran Duodecimin,, Societas Gerontologica Fennican, Suomen Neurologisen Yhdistyksen, Suomen Psykogeriatrisen Yhdistyksen, Suomen Yleislääketieteen Yhdistyksen Asettama Työryhmä.

Duodecim · 2010-01-01

PMID: 21072963

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Treatment of drooling in patients with parkinsonism].

van Onna M, van Laar T.

Ned Tijdschr Geneeskd · 2010-01-01

PMID: 21083950

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

An EMG-based system for continuous monitoring of clinical efficacy of Parkinson's disease treatments.

Askari S, Zhang M, Won DS.

Annu Int Conf IEEE Eng Med Biol Soc · 2010-01-01

DOI: 10.1109/iembs.2010.5626133PMID: 21095645

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Introductory remarks: Catechol-O-methyltransferase inhibition--an innovative approach to enhance L-dopa therapy in Parkinson's disease with dual enzyme inhibition.

Nissinen E.

Int Rev Neurobiol · 2010-01-01

DOI: 10.1016/b978-0-12-381326-8.00001-6PMID: 21095456

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Insights into structure-activity relationships and CNS therapeutic applications of NR2B selective antagonists.

Beinat C, Banister S, Moussa I, Reynolds AJ, McErlean CS, Kassiou M.

Curr Med Chem · 2010-01-01

DOI: 10.2174/092986710793348572PMID: 20939817

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Treatment of dysautonomia in extrapyramidal disorders.

Ziemssen T, Reichmann H.

Ther Adv Neurol Disord · 2010-01-01

DOI: 10.1177/1756285609348902PMID: 21180636

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Modulation of excessive neuronal activity by fibroblasts: potential use in treatment of Parkinson's disease.

Finberg JP, Gluzman Z, Reshef M, Loboda Y, Mohsen U, Bressler-Stramer T, Miari R, Gepstein L, Marom S, Feld Y.

Restor Neurol Neurosci · 2010-01-01

DOI: 10.3233/rnn-2010-0551PMID: 21209495

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Pharmacotherapy of motor manifestations in late stages of Parkinson's disease].

Bogdanov RR, Kotov SV, Kunitsyna AN, Turbina LG.

Zh Nevrol Psikhiatr Im S S Korsakova · 2010-01-01

PMID: 21183918

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

22.626 articles found

Gene therapy for dopamine replacement.

Neurotrophic factor therapy for Parkinson's disease.

[New concepts of pathogenesis, diagnosis, and treatment of neurodegenerative diseases].

Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (Duodopa®) in Sweden.

[Update on current care guidelines. The diagnosis and medical treatment of memory disorders].

[Treatment of drooling in patients with parkinsonism].

An EMG-based system for continuous monitoring of clinical efficacy of Parkinson's disease treatments.

Introductory remarks: Catechol-O-methyltransferase inhibition--an innovative approach to enhance L-dopa therapy in Parkinson's disease with dual enzyme inhibition.

Insights into structure-activity relationships and CNS therapeutic applications of NR2B selective antagonists.

Treatment of dysautonomia in extrapyramidal disorders.

Modulation of excessive neuronal activity by fibroblasts: potential use in treatment of Parkinson's disease.

[Pharmacotherapy of motor manifestations in late stages of Parkinson's disease].

Filters